VANCOUVER, British Columbia, May 21, 2014 (GLOBE NEWSWIRE) -- Aquinox Pharmaceuticals, Inc. ("Aquinox") (Nasdaq:AQXP), a clinical stage pharmaceutical company discovering and developing targeted therapeutics for inflammatory disease and cancer, today announced that David Main, Aquinox's Chief Executive Officer, will present at two upcoming investor conferences.
Jefferies 2014 Global Healthcare Conference |
Monday, June 2, 2014, at 3:00 P.M. Eastern Time |
Grand Hyatt Hotel in New York, NY |
A live audio webcast and archive of the event will be available at: http://wsw.com/webcast/jeff82/AQXP |
2014 Bloom Burton & Co. Healthcare Investor Conference |
Wednesday, June 18, 2014, at 9:30 A.M. Eastern Time |
Toronto Board of Trade in Toronto, Canada |
The corporate overview being presented at both conferences will be available at http://aqxpharma.com/content/corporate-presentation.
About Aquinox Pharmaceuticals
Aquinox Pharmaceuticals, Inc. is a clinical stage pharmaceutical company discovering and developing novel, small molecule therapeutics targeting SH2-containing inositol-5'-phosphatase 1 ("SHIP1") for the treatment of inflammatory disease and cancer. For more information please visit www.aqxpharma.com.